{"id":16384,"date":"2025-05-12T14:25:22","date_gmt":"2025-05-12T14:25:22","guid":{"rendered":"http:\/\/TheNextWeb=1413595"},"modified":"2025-05-12T14:25:22","modified_gmt":"2025-05-12T14:25:22","slug":"neuralink-rival-inbrain-will-never-take-brain-implants-beyond-healthcare","status":"publish","type":"post","link":"https:\/\/www.londonchiropracter.com\/?p=16384","title":{"rendered":"Neuralink rival Inbrain will \u2018never\u2019 take brain implants beyond healthcare"},"content":{"rendered":"\n

Elon Musk has outlandish plans for Neuralink\u2019s brain-computer interfaces, from giving people \u201c<\/span>superpowers<\/span><\/a>\u201d to <\/span>downloading<\/span><\/a> their memories. Spanish rival Inbrain Neuroelectronics has a simpler goal: improving our health \u2014 and nothing more.<\/span><\/p>\n

\u201cI know Elon Musk might want to use Neuralink to drive a Tesla or something like that, but we will never go beyond therapeutic applications,\u201d Carolina Aguilar, Inbrain\u2019s CEO and co-founder, told TNW.  <\/span><\/p>\n

While Musk<\/a> has captured headlines with futuristic ambitions for human enhancement, Inbrain has been steadily focused on developing its neural interfaces to treat neurological diseases. The company\u2019s tech also stands apart. It\u2019s built on the <\/span>\u201cwonder material\u201d graphene<\/span><\/a>. <\/span><\/p>\n

Graphene is an ultra-thin, strong, flexible material that conducts electricity without degrading. It has the potential to be more effective and less invasive than the metals and polymers employed in brain-computer interfaces by companies like Neuralink, Blackrock Neurotech, or Medtronic.<\/span><\/p>\n

\n
\n
<\/div>\n

\n

The ???? of EU tech<\/p>\n

The latest rumblings from the EU tech scene, a story from our wise ol’ founder Boris, and some questionable AI art. It’s free, every week, in your inbox. Sign up now!<\/p>\n<\/div>\n<\/div>\n<\/div>\n

Inbrain\u2019s device is made up of tiny graphene electrodes on a film thinner than a human hair. The implant reads electrical signals from the brain and, when necessary, sends electrical pulses back. It\u2019s designed to treat neurological disorders by targeting the root cause: faulty brain signals. <\/span><\/p>\n

Inbrain\u2019s first focus is Parkinson\u2019s disease. Its graphene-based implant is designed to detect specific neural signals tied to motor function, then deliver ultra-precise stimulation only when needed. \u201cIt won\u2019t cure the disease, but it will cure the symptoms of it,\u201d said <\/span>Aguilar.<\/span><\/p>\n

From the lab to the human brain<\/h2>\n

Last year, Inbrain carried out the world\u2019s first in-human trial of its graphene-based implant at the University of Manchester. <\/span><\/p>\n

Surgeons temporarily placed the device on a patient\u2019s brain during tumour surgery. In just 79 minutes, it identified healthy and cancerous tissue with micrometre precision. Inbrain now plans to test the device in up to 10 patients to assess graphene\u2019s safety in the brain, as part of the EU\u2019s <\/span>\u20ac1bn<\/span> Graphene Flagship<\/span><\/a> project. <\/span><\/p>\n

After that, Inbrain aims to begin clinical trials of its therapeutic implant for Parkinson\u2019s disease, said Aguilar. <\/span><\/p>\n

That system will combine two components: a thin, cellophane-like sheet that rests on the brain\u2019s surface to read electrical activity, and a second, deeper implant that delivers highly targeted stimulation to areas controlling movement. <\/span><\/p>\n

\u201cWith artificial intelligence, the device can learn from each patient\u2019s brain to deliver personalised neurological therapy,\u201d Aguilar explained.  <\/span><\/p>\n

But that\u2019s just the beginning. Inbrain hopes to use the same closed-loop system to tackle conditions such as epilepsy, dementia, and chronic pain. Ultimately, it could help restore lost functions like speech or movement in patients with neurological damage. <\/span><\/p>\n

Founded in 2020, Inbrain has raised $100mn to date, according to <\/span>Aguilar<\/span>. That includes a $50mn Series B round closed last year and a $4.5mn grant from the <\/span>Spanish Ministry of Industry and Tourism, <\/span>announced last week. When asked about the company\u2019s future funding<\/a> prospects, <\/span>Aguilar indicated an IPO was an option. <\/span><\/p>\n

\u201cWe want to have the biggest impact as quickly as possible, and if going public is the best route to get there, we\u2019ll take it,\u201d she said.<\/span><\/p>\n

Aguilar also said that they would be open to being acquired by the \u201cright partner\u201d, but added that she\u2019s not sure if Neuralink would be \u201ca good fit.\u201d<\/span><\/p>\n

The future of tech is a key theme of TNW Conference<\/a>, which takes place on June 19-20 in Amsterdam. Tickets for the event are now on sale<\/a> \u2014 use the code TNWXMEDIA2025 at the checkout to get 30%.<\/em><\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Elon Musk has outlandish plans for Neuralink\u2019s brain-computer interfaces, from giving people \u201csuperpowers\u201d to downloading their memories. Spanish rival Inbrain Neuroelectronics has a simpler goal: improving our health \u2014 and nothing more….<\/p>\n","protected":false},"author":1,"featured_media":16385,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/16384"}],"collection":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16384"}],"version-history":[{"count":0,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/16384\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/media\/16385"}],"wp:attachment":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}